See What HealthDay Can Do For You
Contact Us

Sports Participation Seems Safe for Children With LQTS

No cardiac events or deaths in treatment-compliant genotype-positive LQTS pediatric population

TUESDAY, April 21, 2015 (HealthDay News) -- There is no evidence of cardiac events or deaths occurring in treatment-compliant genotype-positive long QT syndrome (LQTS) pediatric patients who participate in sports, according to research published in the March 1 issue of JACC: Clinical Electrophysiology.

Peter F. Aziz, M.D., from the Cleveland Clinic Lerner College of Medicine, and colleagues conducted a retrospective review on genotype-positive patients referred for the evaluation and management of LQTS between 1998 and 2013. Two hundred twelve genotype-positive LQTS pediatric patients were included, of whom 103 participated in sports (average follow-up, 7.1 years).

The researchers identified 105 LQTS-disease-causing mutations (58 percent KCNQ1, 35 percent KCNH2, 6 percent SCN5A, 1 percent KCNE1, and 2 percent KCNE2). All patients were treated with beta-blockade; one patient was intolerant and one patient noncompliant. Twenty-six and 77 patients participated in competitive sports and recreational sports, respectively. During sports participation, no patients had LTQS symptoms. In two patients, five appropriate implantable cardioverter-defibrillator shocks occurred, although none were related to sports participation.

"In this series no cardiac events and no deaths were observed in treatment-compliant LQTS children while participating in sports in 755 patient-years of follow-up," the authors write.

One author disclosed financial ties to Medtronic.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.